• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

春季角结膜炎的患病率:一种罕见疾病?

Prevalence of vernal keratoconjunctivitis: a rare disease?

作者信息

Bremond-Gignac D, Donadieu J, Leonardi A, Pouliquen P, Doan S, Chiambarretta F, Montan P, Milazzo S, Hoang-Xuan T, Baudouin C, Aymé S

机构信息

Service d'Ophtalmologie, Hôpital Robert Debré, APHP, 48 boulevard Sérurier, 75019 Paris, France.

出版信息

Br J Ophthalmol. 2008 Aug;92(8):1097-102. doi: 10.1136/bjo.2007.117812. Epub 2008 Mar 20.

DOI:10.1136/bjo.2007.117812
PMID:18356259
Abstract

OBJECTIVE

To determine the prevalence of vernal keratoconjuntivitis (VKC) in Europe.

METHODS

A cross-sectional survey was mailed to 3003 ophthalmologists from six countries (Finland, France, Italy, The Netherlands, Norway and Sweden) representing 151.9 million inhabitants. Results were analysed per country, and VKC prevalence for the 15 European member states in 2002 was extrapolated. Six hypotheses were used: disease duration (4 or 8 years) combined with three prevalence hypotheses for non-responding ophthalmologists.

RESULTS

The response rate to the survey was 29.5%. The estimates of VKC prevalence in Western Europe (per 10,000 inhabitants) ranged from 1.16 to 10.55. The prevalence of VKC with corneal complications ranged from 0.30 to 2.26. The VKC prevalences per country were in the following ranges: Italy 2.4-27.8, Finland, 0.7-8.4, Sweden 1.2-8.7, The Netherlands 0.6-4.6, France 0.7-3.3 and Norway 0.3-1.9. VKC with corneal complications were: Italy 0.4-4.8, Sweden 0.3-2.4, Finland 0.2-2.8, The Netherlands 0.2-1.6, France 0.3-1.4 and Norway 0.1-1.0.

CONCLUSIONS

Based on the most likely hypotheses concerning disease duration and non-responding ophthalmologists' VKC case rate, the best estimate of VKC prevalence in Western Europe is 3.2/10,000 inhabitants. The prevalence of VKC with corneal complications is 0.8/10,000 inhabitants.

摘要

目的

确定欧洲春季角结膜炎(VKC)的患病率。

方法

向来自六个国家(芬兰、法国、意大利、荷兰、挪威和瑞典)的3003名眼科医生邮寄了一份横断面调查问卷,这六个国家的居民总数为1.519亿。对每个国家的结果进行了分析,并推算出2002年15个欧洲成员国的VKC患病率。使用了六个假设:疾病持续时间(4年或8年)与针对未回复的眼科医生的三种患病率假设相结合。

结果

调查的回复率为29.5%。西欧VKC患病率(每10000居民)的估计范围为1.16至10.55。伴有角膜并发症的VKC患病率范围为0.30至2.26。每个国家的VKC患病率在以下范围内:意大利2.4 - 27.8,芬兰0.7 - 8.4,瑞典1.2 - 8.7,荷兰0.6 - 4.6,法国0.7 - 3.3,挪威0.3 - 1.9。伴有角膜并发症的VKC患病率为:意大利0.4 - 4.8,瑞典0.3 - 2.4,芬兰0.2 - 2.8,荷兰0.2 - 1.6,法国0.3 - 1.4,挪威0.1 - 1.0。

结论

基于关于疾病持续时间和未回复的眼科医生的VKC病例率的最可能假设,西欧VKC患病率的最佳估计为每10000居民3.2例。伴有角膜并发症的VKC患病率为每10000居民0.8例。

相似文献

1
Prevalence of vernal keratoconjunctivitis: a rare disease?春季角结膜炎的患病率:一种罕见疾病?
Br J Ophthalmol. 2008 Aug;92(8):1097-102. doi: 10.1136/bjo.2007.117812. Epub 2008 Mar 20.
2
Vernal keratoconjunctivitis in school children in Rwanda: clinical presentation, impact on school attendance, and access to medical care.卢旺达学童的春季角结膜炎:临床表现、对入学的影响和获得医疗的途径。
Ophthalmology. 2012 Sep;119(9):1766-72. doi: 10.1016/j.ophtha.2012.03.041. Epub 2012 Jun 7.
3
Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population.春季角结膜炎的前瞻性、多中心人口统计学和流行病学研究:意大利人群眼表一瞥
Ophthalmic Epidemiol. 2009 Jan-Feb;16(1):38-41. doi: 10.1080/09286580802573177.
4
Vernal keratoconjunctivitis: modes of presentation in Nepalese population.春季角结膜炎:尼泊尔人群中的表现形式
Kathmandu Univ Med J (KUMJ). 2007 Oct-Dec;5(4):526-30.
5
[Vernal keratoconjunctivitis in children].[儿童春季角结膜炎]
Klin Oczna. 2005;107(1-3):86-9.
6
Penetrating keratoplasty for keratoconus with or without vernal keratoconjunctivitis.穿透性角膜移植术治疗圆锥角膜伴或不伴春季角结膜炎。
Cornea. 2009 Jan;28(1):14-8. doi: 10.1097/ICO.0b013e31818225dd.
7
Vernal Keratoconjunctivitis in Kashmir: A temperate zone.克什米尔地区的春季角结膜炎:一个温带地区。
Int Ophthalmol. 2016 Dec;36(6):875-879. doi: 10.1007/s10792-016-0213-8. Epub 2016 Mar 10.
8
The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis.特应性角结膜炎和春季角结膜炎患者泪液功能及眼表表现的差异
Allergy. 2007 Aug;62(8):917-25. doi: 10.1111/j.1398-9995.2007.01414.x.
9
Limbal vernal keratoconjunctivitis: clinical characteristics and immunoglobulin E expression compared with palpebral vernal.角膜缘春季角结膜炎:与睑结膜春季角结膜炎相比的临床特征及免疫球蛋白E表达
Eye (Lond). 1989;3 ( Pt 4):420-7. doi: 10.1038/eye.1989.63.
10
Long eyelashes in a case series of 93 children with vernal keratoconjunctivitis.93例春季角结膜炎患儿病例系列中的长睫毛情况
Pediatrics. 2005 Jan;115(1):e86-91. doi: 10.1542/peds.2004-1555.

引用本文的文献

1
The psychological impact of vernal keratoconjunctivitis on families: An investigation on quality of life and psychological wellbeing.春季角结膜炎对家庭的心理影响:一项关于生活质量和心理健康的调查
Pediatr Allergy Immunol. 2025 Jul;36(7):e70141. doi: 10.1111/pai.70141.
2
Unpacking VKC: How gender and age shape the clinical picture.剖析春季角结膜炎:性别和年龄如何塑造临床表现。
Indian J Ophthalmol. 2025 Apr 1;73(4):594-598. doi: 10.4103/IJO.IJO_177_25. Epub 2025 Mar 27.
3
Corticosteroid-sparing topical treatment with cyclosporin for juvenile keratoconjunctivitis.
环孢素用于青少年角结膜炎的糖皮质激素节省型局部治疗
Sci Rep. 2025 Feb 8;15(1):4671. doi: 10.1038/s41598-025-85256-z.
4
Sex hormones and allergies: exploring the gender differences in immune responses.性激素与过敏:探索免疫反应中的性别差异。
Front Allergy. 2025 Jan 7;5:1483919. doi: 10.3389/falgy.2024.1483919. eCollection 2024.
5
Seeing eye to eye: a modified Delphi method-based multidisciplinary expert consensus on the diagnosis and treatment of vernal keratoconjunctivitis.意见一致:基于改良 Delphi 法的多学科专家对春季角结膜炎诊断和治疗的共识。
Eur J Pediatr. 2024 Nov;183(11):5053-5061. doi: 10.1007/s00431-024-05776-0. Epub 2024 Sep 26.
6
Long-Term Observation of Prognostic Factors and Clinical Outcome of Vernal Keratoconjunctivitis in Childhood.儿童春季角结膜炎预后因素及临床结局的长期观察
Clin Ophthalmol. 2024 Aug 23;18:2339-2347. doi: 10.2147/OPTH.S472826. eCollection 2024.
7
Health-related Quality of Life in Children with Vernal Keratoconjunctivitis in Malaysia.马来西亚春季角结膜炎儿童的健康相关生活质量。
Korean J Ophthalmol. 2024 Oct;38(5):364-374. doi: 10.3341/kjo.2024.0048. Epub 2024 Aug 16.
8
Vernal keratoconjunctivitis in adults: a narrative review of prevalence, pathogenesis, and management.成人春季角结膜炎:患病率、发病机制及治疗的叙述性综述
Front Ophthalmol (Lausanne). 2024 Feb 15;4:1328953. doi: 10.3389/fopht.2024.1328953. eCollection 2024.
9
Development and validation of a health practitioner survey on ocular allergy.眼科过敏健康从业者调查问卷的制定与验证。
Sci Rep. 2024 Apr 30;14(1):9932. doi: 10.1038/s41598-024-60837-6.
10
Reserve drug as first-line management: Topical interferon α-2b for vernal keratoconjunctivitis.储备药物作为一线治疗:局部应用干扰素 α-2b 治疗春季角结膜炎。
Indian J Ophthalmol. 2024 Jul 1;72(7):1007-1011. doi: 10.4103/IJO.IJO_1393_23. Epub 2024 Mar 8.